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Design of a text-processing algorithm for
extracting data on signs and symptoms from
free text electronic medical records
M. Chen
National University of Singapore, Singapore, NA,
Singapore
Background: Electronic medical records (EMR) are a poten-
tial source of syndromic data for surveillance, but require text
processing algorithms to extract relevant data.
Methods & Materials: We analysed free text EMR for a pre-
deﬁned set of 28 signs and symptoms (Box). We useda “compiler
approach” to transform EMR text by ﬁrst tokenizing source text,
and then parsing these tokens according to some grammar rules.
Patterns andgrammar ruleswere created fromapilot set ofmedical
records from 50 episodes of care. Patterns for each sign/symptom
include the sign/symptom itself, common misspellings, and syn-
onyms. Patterns for keywords were also created to capture
contextual features. To deﬁne the presence of a sign or symptom,
we want to know if a symptom is either afﬁrmed, negated or not
mentioned. To do so, we had to capture keywords that will change
the status of a symptom (e.g. negative words such as “no”, “nil”,
“denies”) and conjunction keywords such as “and”, “or”, “,”, “/”
which are used to chain a list of symptoms together.
Manual coding by a nurse familiar with EMR shorthand and
abbreviations was used as the gold standard against which text
processing algorithm was compared.
Box: List of signs and symptoms considered
Results: The results for a section of the raw EMR text and
the processed result, highlight how the algorithm could accurately
classify a symptom appearing in the text as either afﬁrmed (e.g.
“myalgia” and “fever”, which were present “x1/7”, i.e. 1 day), or
negated (e.g. no chest pain) and deal with misspelt words and
abbreviations. For instance, the algorithmrecognises the string “-
no ST/RN/cough” to refer to all three symptoms of sore throat, rhi-
norrhea and cough being negated.
In the 50 episodes of care analysed, there were 107 signs
and symptoms “negated” and 179 “afﬁrmed” by manual coding
(Table 1). Machine classiﬁcation achieved a sensitivity of 97% for
detecting signs/symptoms that are “afﬁrmed” on manual coding;
speciﬁcity was 96% “negated” signs/symptomsas the negatives,
and>99% when including as negatives both signs/symptoms that
are “negated” and absent by manual coding.
Conclusion: Our algorithm ispotentially useful for syn-
dromic surveillance.
Table 1
Comparison of machine and manual coding
http://dx.doi.org/10.1016/j.ijid.2014.03.714
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Development and evaluation of a multiple-locus
variable-number tandem-repeats analysis assay
for subtyping Salmonella typhi strains from
Sub-Saharan Africa
N. Tau, A.M. Smith, K.H. Keddy ∗
Centre for Enteric Diseases, National Institute for
Communicable Diseases; Faculty of Health Sciences,
University of the Witwatersrand, Johannesburg,
South Africa
Background: Typhoid fever a major public health prob-
lem in developing countries. Epidemiological investigations of
Salmonella enterica serovar Typhi (Salmonella Typhi) infections
using molecular sub-typing methods are challenging due to the
highly homologous nature of Salmonella Typhi strains. In recent
years, several approaches in using multiple-locus variable-number
tandem-repeats analysis (MLVA) for molecular sub-typing of
Salmonella Typhi have been made. To date, a standardized set
of variable-number tandem-repeats (VNTR) loci for the typing of
homologous Salmonella Typhi strains has not been established.
The aim of our study was to develop and evaluate a MLVA assay
consisting of 5 VNTR markers to analyse Salmonella Typhi strains
from Sub-Saharan Africa (SSA).
Methods&Materials: To develop and evaluate theMLVA assay,
50 Salmonella Typhi strains from humans were selected from
the culture collection at the Centre for Enteric Diseases (CED) at
the National Institute for Communicable Diseases (NICD) from a
potential 1080 isolates. This strain panel represented the diverse
Salmonella Typhi pulsed-ﬁeld gel electrophoresis (PFGE) proﬁles in
the CED database, specimen collection dates and geographic areas
within the SSA region. The 50 Salmonella Typhi strains were used
to evaluate 12 polymorphic VNTR loci that were previously pub-
lished. These include TR1, TR2, TR3, TR4, TR5, Sal02, Sal06, Sal10,
Sal16, Sal20, TR4500 and TR4600. The assay included PCR ampli-
ﬁcation of VNTR loci using ﬂuorescently labelled primers and size
determination of PCR products by capillary electrophoresis.
Results: Of the 12 VNTR loci that were evaluated, 5 (TR3,
TR4, TR5, Sal06, Sal10 and TR4500) were found unsuitable as
they showed poor allele variation (between 1 and 3 alleles). The
remaining6VNTR loci showedgoodallele variationandgooddiver-
sity indices; with Sal20, Sal 16 and TR1 having 6, 9 and 11 alleles
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respectively; and Sal02, TR4699 and TR2 having 15, 20 and 23
alleles respectively.
Conclusion: In summary, we have identiﬁed 6 polymorphic
VNTR loci suitable for MLVA analysis of Salmonella Typhi strains.
The ﬁvemost diverse VNTR loci will be selected for theMLVA assay
and will be used to analyse Salmonella Typhi strains from SSA. This
work will assist in rapidly identifying strain relatedness and assist
outbreak detection in typhoid fever outbreaks.
http://dx.doi.org/10.1016/j.ijid.2014.03.715
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Co-infection of malaria and inﬂuenza viruses in
Uganda: A pilot study
B. Namagambo1,∗, J.T. Kayiwa1, T. Byaruhanga1,
N. Owor1, I. Nabukenya1, B. Bakamutumaho2, J.J.
Lutwama3
1 Uganda Virus Research Institute, Entebbe, Uganda
2 Uganda Virus Research Institute, Kampala, Uganda
3 Uganda Virus Research Institute, Entebbe, Uganda
Background: Inﬂuenza is a highly contagious viral infection of
the respiratory passages causing fever, headache, severe aching,
cough, and periodically causes epidemics especially in temper-
ate environments. In many African countries, people do not visit
clinics or hospitals with just inﬂuenza infection. Majority of ILI
patients do not seekmedical care and very few of thosewho do, get
tested for inﬂuenza. The many of inﬂuenza cases that are reported
by surveillance programs are from sentinel sites where patients
come in with other medical problems. Clinically, inﬂuenza is not
distinguishable from most other infectious diseases with fever in
the tropics. Malaria is an important infectious disease and is still
thought to be the main cause of febrile episodes. Most fevers are
thought to be malaria. Our investigations sort to establish infor-
mation on incidence of malaria in patients who are positive with
Inﬂuenza infection.
Methods&Materials:This cross-sectionalpilot studyexamined
incidence of malaria among outpatient visits and hospitalizations
associatedwith Inﬂuenza like Illnesses (ILI) andSevereAcuteRespi-
ratory Illness (SARI) during the period February 2011-November
2013 in children, youth and adults attending six health facilities
of; Kawaala health centre III, Kitebi Health centre III, UVRI Clinic,
EntebbeHospital andMbarara Regional referral hospital inUganda.
Nasopharyngeal and oralpharyngeal swabs were collected from
patientsmeeting theWHOcasedeﬁnition for ILI andSARI. Inﬂuenza
viruses were screened for using RT- PCR and the clinical data pre-
senting diagnosis of malaria was collected and analyzed.
Results: Out of the 1020inﬂuenza specimens collected from
cases; 754 (73.9%) patientswere diagnosedwithmalaria; 116 (15%)
of 754 were positive for Inﬂuenza and 638 (84.6%) were negative;
positive for Inﬂuenza A were 71(9.4%) with two subtypes; 56(7.4%)
A(H3) and 15(2.6%) Pandemic A(H1N1) 2009, and 45 (6.0%) were
Inﬂuenza B viruses. Of the 116 positives 108(93.1%) were ILI and
8(6.9%) were SARI patients. Although 107 (92.2%) Children diag-
nosed with Malaria had Inﬂuenza, 9 (7.8%) Youth had Inﬂuenza
whereas there was no Inﬂuenza in Adult.
Conclusion: Our data shows a high incidence of Inﬂuenza in
children diagnosed with malaria.
http://dx.doi.org/10.1016/j.ijid.2014.03.716
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Clostridium difﬁcile infection in University
Hospital Trnava: A hospital-based survey
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Macekova4, J. Brnova5
1 University Hospital Trnava, Trnava, Slovakia
2 Trnava University, School of Health Sciences and
Social Work, Trnava, Slovakia
3 Faculty of Social Sciences and Health
Care,Constantine the Philosopher University, Nitra,
Slovakia
4 Analytx s.r.o., Trnava, Slovakia
5 Trnava University, School of Public Health Social
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Background: Clostridium difﬁcile infection (CDI) have
increased in frequency and severity over the past decade and
are a leading cause of hospital acquired infections. In Slovakia,
mandatory surveillance of Clostridium difﬁcile infection and
others health care associated infection was established due to
electronically national Epidemiological information systems
(EPIS). But only a few cases of CDI were reported as a healthcare
associated infection in EPIS during last years. Therefore the aim of
this hospital-based survey was to assess incidence, risk factors and
outcome of CDI in University Hospital Trnava, Slovakia in period
2010-2012.
Methods & Materials: We analysed all patients with laboratory
conﬁrmed CDI in University Hospital Trnava during three years
period (RIDA®QUICK Clostridium difﬁcile Toxin A/B immunochro-
matographic rapid assay for the qualitative determination of the
toxins A and B of Clostridium difﬁcile in stool samples, R-Biopharm).
Incidence rate per 10000 hospitalized patientswere calculated and
patients characteristic were recorded from hospital information
systems.
Results: Together 208 hospitalized patients were conﬁrmed
Clostridium difﬁcile toxin in stool samples. Incidence of CDI in
hospitalized patients during three years period 2010, 2011, 2012
increased 24/10 000, 27/10 000, 32/10 000 respectively. Health
care –associated CDI were more often identiﬁed than community-
acquired CDI (73,6% vs. 26,4%). Mean age of infected patients
were 73±16 (range 15-96) and female (60%) were more fre-
quent infected than male. The most affected were Geriatric
Department (29,3%), Department of Infectious Diseases (25%)
and Department of Internal Medicine (24%). Concerning risk fac-
tors, most patients before development CDI received antibiotics -
ciproﬂoxacin, cefuroxime and ampicillin/sulbactam due to respira-
tion or urinary tract infection. Recurrence of CDI was conﬁrmed in
7,7% patients and occurring within 3 months after the ﬁrst episode.
Almost all cases (99%) were treated with metronidazole, others 4
cases with rifaximin (2), vancomycin (1) and ﬁdaxomicínom (1).
Death associated with CDI was observed in two patients.
